Founder and Vice President , MX Biotech Ltd.erusalem, Israel
Biography
Dr. Marx has wide knowledge of blood biochemistry and medical applications of fibrinogen-based medical applications of fibrinogen-based materials; Experience in GMP fractionation of blood plasma proteins, including pre-clinical animal studies to support FDA licensure for Fibrin Sealant; Developed liposome and Haptide patents from transdermal drug delivery; Author of more than 60 published articles and 10 US patents, as well as a recent chapter in “Fibrinogen: Science and Biotechnology” in Production of Plasma Proteins for Therapeutic Use, Chapter 9, Bertolini J., Goss N., Curling J. (Eds). John Wiley & Sons, New York.
+44 1478 350008